Tumour suppressor function of MDA-7/IL-24 in human breast cancer

Neill Patani1, Anthony Douglas-Jones, Robert Mansel

  • 1Department of Breast Surgery, The London Breast Institute, The Princess Grace Hospital, 42-52 Nottingham Place, W1U-5NY, London, UK. kefahmokbel@hotmail.com.

Abstract

Insights

Melanoma differentiation associated gene-7 (MDA-7) inhibits breast cancer cell migration and is less expressed in malignant tissues. Lower MDA-7 levels correlate with poorer prognosis and reduced survival, suggesting its potential as a prognostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Melanoma differentiation associated gene-7 (MDA-7), also known as interleukin (IL)-24, is a tumor suppressor gene.
  • Its anti-neoplastic mechanisms, tumor specificity, and efficacy across various cancers require further elucidation.
  • This study investigates the biological impact of MDA-7 on breast cancer (BC) cells and its expression correlation with clinical outcomes.

Purpose of the Study:

  • To evaluate the in-vitro biological impact of MDA-7 on breast cancer cell behavior.
  • To assess MDA-7 mRNA expression in a cohort of women with breast cancer.
  • To correlate MDA-7 expression with pathological parameters and clinical outcomes.

Main Methods:

  • Utilized the MDA MB-231 human breast cancer cell line to assess the in-vitro effects of recombinant human (rh)-MDA-7 on cell growth and motility.
  • Employed wound healing assays, electric cell impedance sensing (ECIS), and immunohistochemistry for MDA-7 localization.
  • Analyzed MDA-7 transcript levels via real-time quantitative PCR in 127 breast cancer tissues and 33 normal tissues, correlating with pathological parameters and 10-year clinical outcomes.

Main Results:

  • rh-MDA-7 significantly reduced breast cancer cell migration and wound closure in-vitro, with a marginal effect on growth.
  • Immunohistochemistry revealed significantly greater MDA-7 positivity in normal breast tissues compared to cancer tissues.
  • Lower MDA-7 transcript levels were significantly associated with poorer prognosis (NPI), node-positive tumors, and shorter disease-free survival.

Conclusions:

  • MDA-7 significantly inhibits breast cancer cell motility and migration in-vitro.
  • MDA-7 expression is substantially reduced in malignant breast tissue.
  • Low MDA-7 transcript levels correlate with unfavorable pathological parameters and adverse clinical outcomes, indicating its potential as a prognostic marker and therapeutic target.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...